DIANIA TECHNOLOGIES LIMITED

Their core work

Diania Technologies is an Irish medical device manufacturing SME specialising in advanced extrusion-based lubrication technology for catheter production. Their core innovation addresses two critical manufacturing problems in minimally invasive medical devices: reducing surface friction on catheter walls and preventing delamination of coating layers during and after manufacture. They work on transitioning catheter manufacturers from discrete (batch) production toward lean, continuous manufacturing processes — a significant operational and cost challenge in the sector. Their H2020 work was focused entirely on commercialising this technology, suggesting a product company rather than a pure research outfit.

What they specialise in

How they've shifted over time

Diania's H2020 trajectory is a textbook SME Instrument journey: a 2015 Phase 1 feasibility study (€50k) with no detailed keywords on record, followed by a substantially funded Phase 2 commercialisation project (€1.75M, 2017–2020) with a fully articulated technical profile. The absence of early-period keywords reflects the exploratory nature of Phase 1, while the recent keyword cluster — catheters, low friction, delamination, lean manufacturing — marks a decisive pivot to a specific medical device niche. By the end of their H2020 participation, the company had narrowed from broad extrusion technology into a focused solution for catheter manufacturers specifically.

Diania is moving toward deeper specialisation in medical device manufacturing efficiency — specifically catheter production — and is at a commercialisation stage, making them a potential technology vendor rather than a research collaborator.

How they like to work

Diania has acted exclusively as project coordinator across both H2020 projects, and both were solo SME Instrument grants — a funding scheme specifically designed for single companies without consortium requirements. This means there is no evidence of multi-partner collaboration or network building through EU projects. For anyone considering working with them, they are most likely a technology provider or licensing partner rather than an experienced consortium member.

Diania has no recorded consortium partners from their H2020 participation — both projects were sole-beneficiary SME Instrument grants. Their collaboration network, if any, exists outside the EU project system and is not visible in this data.

What sets them apart

Diania occupies a very specific niche: extrusion-based lubrication solutions for catheter manufacturers looking to reduce friction, prevent coating delamination, and shift toward leaner production. Few SMEs combine materials science (polymer extrusion), medical device knowledge, and manufacturing process transformation in a single product offering. Their successful progression through both phases of the EU SME Instrument is an independent validation of commercial viability — a signal worth noting for potential industrial partners or investors in the medtech supply chain.

Highlights from their portfolio

• ExtruLub
  The Phase 2 grant (€1.75M, 2017–2020) is one of the largest SME Instrument Phase 2 awards and represents full EU-backed commercialisation of a catheter lubrication technology addressing friction and delamination — two persistent failure points in minimally invasive device manufacturing.
• ExtruLub
  The Phase 1 project (2015) is notable as proof that Diania successfully passed the highly competitive SME Instrument feasibility gate, which typically screens out the majority of applicants before Phase 2 funding is awarded.